DK277488A - Phosporholdige hmg-coa-reduktaseinhibitorer, deres anvendelse og fremstilling samt mellemprodukter ved fremstillingen - Google Patents

Phosporholdige hmg-coa-reduktaseinhibitorer, deres anvendelse og fremstilling samt mellemprodukter ved fremstillingen

Info

Publication number: DK277488A
Authority: DK; Denmark
Prior art keywords: hmg; phosphorus; preparation; manufacturing; coa reductase
Prior art date: 1987-05-22

Application number

DK277488A

Other languages

English (en)

Other versions

DK277488D0 (da

Inventor

Donald Steven Karanewsky

Scott Adams Biller

Eric Michael Gordon

Original Assignee

Squibb & Sons Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-22

Filing date

1988-05-20

Publication date

1988-11-23

1988-05-20 Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc

1988-05-20 Publication of DK277488D0 publication Critical patent/DK277488D0/da

1988-11-23 Publication of DK277488A publication Critical patent/DK277488A/da

Links

229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 title 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title 1
239000013067 intermediate product Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
229910052698 phosphorus Inorganic materials 0.000 title 1
239000011574 phosphorus Substances 0.000 title 1
229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
- C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/36—Amides thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/44—Amides thereof
- C07F9/4403—Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4407—Amides of acyclic saturated acids which can have further substituents on alkyl

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK277488A 1987-05-22 1988-05-20 Phosporholdige hmg-coa-reduktaseinhibitorer, deres anvendelse og fremstilling samt mellemprodukter ved fremstillingen DK277488A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5328187A	1987-05-22	1987-05-22
US10968087A	1987-10-19	1987-10-19

Publications (2)

Publication Number	Publication Date
DK277488D0 DK277488D0 (da)	1988-05-20
DK277488A true DK277488A (da)	1988-11-23

Family

ID=26731667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK277488A DK277488A (da)	1987-05-22	1988-05-20	Phosporholdige hmg-coa-reduktaseinhibitorer, deres anvendelse og fremstilling samt mellemprodukter ved fremstillingen

Country Status (24)

Country	Link
JP (1)	JP2680347B2 (da)
KR (1)	KR880013958A (da)
CN (1)	CN88103091A (da)
AU (1)	AU610591B2 (da)
BE (1)	BE1004193A3 (da)
CH (1)	CH676984A5 (da)
DE (1)	DE3817375C2 (da)
DK (1)	DK277488A (da)
ES (1)	ES2009918A6 (da)
FI (1)	FI89493C (da)
FR (1)	FR2615508B1 (da)
GB (1)	GB2205837B (da)
GR (1)	GR1000959B (da)
HU (1)	HU205125B (da)
IE (2)	IE63760B1 (da)
IL (1)	IL86464A (da)
IT (1)	IT1217685B (da)
NL (1)	NL8801330A (da)
NO (1)	NO882218L (da)
NZ (1)	NZ224733A (da)
PH (1)	PH25350A (da)
PL (1)	PL154877B1 (da)
PT (1)	PT87539B (da)
SE (1)	SE503210C2 (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU610174B2 (en) *	1987-05-22	1991-05-16	E.R. Squibb & Sons, Inc.	Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
CA2007643A1 (en) *	1989-02-01	1990-08-01	Donald S. Karanewsky	Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination
CA2042526A1 (en) *	1990-06-11	1991-12-12	Adeoye Y. Olukotun	Method for preventing a second heart attack employing an hmg coa reductase inhibitor
US5202327A (en) *	1991-07-10	1993-04-13	E. R. Squibb & Sons, Inc.	Phosphorus-containing hmg-coa reductase inhibitors
GB9126144D0 (en) *	1991-12-10	1992-02-12	British Bio Technology	Compounds
US20010006644A1 (en)	1997-07-31	2001-07-05	David J. Bova	Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
CA2344300A1 (en)	1998-09-17	2000-03-23	Jeffrey A. Robl	Method for treating atherosclerosis employing an ap2 inhibitor and combination
ES2258141T3 (es)	2001-04-11	2006-08-16	Bristol-Myers Squibb Company	Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento.
KR20040054729A (ko)	2001-10-18	2004-06-25	브리스톨-마이어스 스큅 컴퍼니	인간 글루카곤-유사-펩티드-1 모방체, 및 당뇨병 및 이와관련된 증상의 치료에 있어서 이의 용도
US7238671B2 (en)	2001-10-18	2007-07-03	Bristol-Myers Squibb Company	Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US6806381B2 (en)	2001-11-02	2004-10-19	Bristol-Myers Squibb Company	Process for the preparation of aniline-derived thyroid receptor ligands
US7057046B2 (en)	2002-05-20	2006-06-06	Bristol-Myers Squibb Company	Lactam glycogen phosphorylase inhibitors and method of use
ATE469645T1 (de)	2002-10-23	2010-06-15	Bristol Myers Squibb Co	Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
US7098235B2 (en)	2002-11-14	2006-08-29	Bristol-Myers Squibb Co.	Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
TW200504021A (en)	2003-01-24	2005-02-01	Bristol Myers Squibb Co	Substituted anilide ligands for the thyroid receptor
US7459474B2 (en)	2003-06-11	2008-12-02	Bristol-Myers Squibb Company	Modulators of the glucocorticoid receptor and method
US6995183B2 (en)	2003-08-01	2006-02-07	Bristol Myers Squibb Company	Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
US8158362B2 (en)	2005-03-30	2012-04-17	Decode Genetics Ehf.	Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
NZ549721A (en)	2004-03-05	2010-08-27	Univ Pennsylvania	Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
TW200611704A (en)	2004-07-02	2006-04-16	Bristol Myers Squibb Co	Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
US7145040B2 (en)	2004-07-02	2006-12-05	Bristol-Myers Squibb Co.	Process for the preparation of amino acids useful in the preparation of peptide receptor modulators
US7534763B2 (en)	2004-07-02	2009-05-19	Bristol-Myers Squibb Company	Sustained release GLP-1 receptor modulators
AR051446A1 (es)	2004-09-23	2007-01-17	Bristol Myers Squibb Co	Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
US7517991B2 (en)	2004-10-12	2009-04-14	Bristol-Myers Squibb Company	N-sulfonylpiperidine cannabinoid receptor 1 antagonists
US7589088B2 (en)	2004-12-29	2009-09-15	Bristol-Myers Squibb Company	Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
US7635699B2 (en)	2004-12-29	2009-12-22	Bristol-Myers Squibb Company	Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
US7368458B2 (en)	2005-01-12	2008-05-06	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076598A2 (en)	2005-01-12	2006-07-20	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076569A2 (en)	2005-01-12	2006-07-20	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid receptor modulators
US20060160850A1 (en)	2005-01-18	2006-07-20	Chongqing Sun	Bicyclic heterocycles as cannabinoid receptor modulators
EP2527337A1 (en)	2005-04-14	2012-11-28	Bristol-Myers Squibb Company	Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
US7521557B2 (en)	2005-05-20	2009-04-21	Bristol-Myers Squibb Company	Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
US7632837B2 (en)	2005-06-17	2009-12-15	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid-1 receptor modulators
TW200726765A (en)	2005-06-17	2007-07-16	Bristol Myers Squibb Co	Triazolopyridine cannabinoid receptor 1 antagonists
US7452892B2 (en)	2005-06-17	2008-11-18	Bristol-Myers Squibb Company	Triazolopyrimidine cannabinoid receptor 1 antagonists
US7629342B2 (en)	2005-06-17	2009-12-08	Bristol-Myers Squibb Company	Azabicyclic heterocycles as cannabinoid receptor modulators
US7317012B2 (en)	2005-06-17	2008-01-08	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoind-1 receptor modulators
US8618115B2 (en)	2005-10-26	2013-12-31	Bristol-Myers Squibb Company	Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
EP2487154B1 (en)	2005-10-31	2013-10-16	Bristol-Myers Squibb Company	Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods
US7592461B2 (en)	2005-12-21	2009-09-22	Bristol-Myers Squibb Company	Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7553836B2 (en)	2006-02-06	2009-06-30	Bristol-Myers Squibb Company	Melanin concentrating hormone receptor-1 antagonists
WO2007139589A1 (en)	2006-05-26	2007-12-06	Bristol-Myers Squibb Company	Sustained release glp-1 receptor modulators
US7919598B2 (en)	2006-06-28	2011-04-05	Bristol-Myers Squibb Company	Crystal structures of SGLT2 inhibitors and processes for preparing same
EP2089355A2 (en)	2006-11-01	2009-08-19	Brystol-Myers Squibb Company	Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
AR065809A1 (es)	2007-03-22	2009-07-01	Bristol Myers Squibb Co	Formulaciones farmaceuticas que contienen un inhibidor sglt2
PE20090696A1 (es)	2007-04-20	2009-06-20	Bristol Myers Squibb Co	Formas cristalinas de saxagliptina y procesos para preparar las mismas
KR20100031528A (ko)	2007-06-01	2010-03-22	더 트러스티즈 오브 프린스턴 유니버시티	숙주세포 대사경로의 조절을 통한 바이러스 감염 치료
US20090011994A1 (en)	2007-07-06	2009-01-08	Bristol-Myers Squibb Company	Non-basic melanin concentrating hormone receptor-1 antagonists and methods
CN101808995A (zh)	2007-07-27	2010-08-18	百时美施贵宝公司	新颖的葡糖激酶激活剂及其使用方法
CA2697551C (en)	2007-09-20	2013-03-12	Irm Llc	Piperidine derivatives as modulators of gpr119 activity
PE20091928A1 (es)	2008-05-29	2009-12-31	Bristol Myers Squibb Co	Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
SG174504A1 (en)	2009-03-27	2011-10-28	Bristol Myers Squibb Co	Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
WO2011014520A2 (en)	2009-07-29	2011-02-03	Irm Llc	Compounds and compositions as modulators of gpr119 activity
EA201200570A1 (ru)	2009-10-09	2012-11-30	Айрм Ллк	Соединения и композиции в качестве модуляторов активности gpr119
CN104825417A (zh)	2009-11-13	2015-08-12	阿斯利康(瑞典)有限公司	立即释放片剂
MX2012005425A (es)	2009-11-13	2012-06-14	Astrazeneca Uk Ltd	Formulaciones de metformina de masa reducida.
ES2689107T3 (es)	2009-11-13	2018-11-08	Astrazeneca Ab	Formulaciones de tabletas bicapa
US8394858B2 (en)	2009-12-03	2013-03-12	Novartis Ag	Cyclohexane derivatives and uses thereof
TWI562775B (en)	2010-03-02	2016-12-21	Lexicon Pharmaceuticals Inc	Methods of using inhibitors of sodium-glucose cotransporters 1 and 2
WO2011130459A1 (en)	2010-04-14	2011-10-20	Bristol-Myers Squibb Company	Novel glucokinase activators and methods of using same
CN107080846A (zh)	2010-07-09	2017-08-22	詹姆斯.特林卡.格林	用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统
US8697739B2 (en)	2010-07-29	2014-04-15	Novartis Ag	Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
IL295438B2 (en)	2011-01-05	2026-05-01	Lexicon Pharmaceuticals Inc	Compositions containing and methods for using inhibitors of sodium-glucose cotransporters 1 and 2
WO2014052619A1 (en)	2012-09-27	2014-04-03	Irm Llc	Piperidine derivatives and compositions as modulators of gpr119 activity
EP2925735B1 (en)	2012-11-20	2019-03-13	Lexicon Pharmaceuticals, Inc.	Inhibitors of sodium glucose cotransporter 1
US9593113B2 (en)	2013-08-22	2017-03-14	Bristol-Myers Squibb Company	Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN104610262B (zh) *	2013-11-01	2017-06-06	上海医药工业研究院	联苯类化合物、中间体、制备方法、药物组合物及其应用
EP3288584A2 (en)	2015-04-30	2018-03-07	President and Fellows of Harvard College	Anti-ap2 antibodies and antigen binding agents to treat metabolic disorders
WO2020016335A1 (en)	2018-07-19	2020-01-23	Astrazeneca Ab	Methods of treating hfpef employing dapagliflozin and compositions comprising the same
AU2019346497A1 (en)	2018-09-26	2021-04-08	Lexicon Pharmaceuticals, Inc.	Crystalline forms of n-(1 -((2-(dimethylamino)ethyl)amino)-2-m ethyl-1 -oopropan-2-yl)-4-(4-(2-methyl-5- (2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl) phenl)butanamide and methods of their synthesis
EP4188372A1 (en)	2020-07-29	2023-06-07	Amryt Pharmaceuticals Inc.	Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA828650B (en) *	1981-12-01	1983-09-28	Hunt Chem Corp Philip A	Herbicidal compositions and method using phosphonalkanoic acids, esters and salts thereof
FR2596393B1 (fr) *	1986-04-01	1988-06-03	Sanofi Sa	Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
AU610174B2 (en) *	1987-05-22	1991-05-16	E.R. Squibb & Sons, Inc.	Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method

1988
- 1988-05-20 DK DK277488A patent/DK277488A/da not_active Application Discontinuation
- 1988-05-20 AU AU16508/88A patent/AU610591B2/en not_active Ceased
- 1988-05-20 IE IE154388A patent/IE63760B1/en not_active IP Right Cessation
- 1988-05-20 IL IL86464A patent/IL86464A/xx not_active IP Right Cessation
- 1988-05-20 HU HU882614A patent/HU205125B/hu not_active IP Right Cessation
- 1988-05-20 GR GR880100331A patent/GR1000959B/el unknown
- 1988-05-20 PH PH36956A patent/PH25350A/en unknown
- 1988-05-20 IE IE930324A patent/IE930324L/xx unknown
- 1988-05-20 NO NO882218A patent/NO882218L/no unknown
- 1988-05-20 NZ NZ224733A patent/NZ224733A/en unknown
- 1988-05-20 PT PT87539A patent/PT87539B/pt not_active IP Right Cessation
- 1988-05-20 ES ES8801610A patent/ES2009918A6/es not_active Expired
- 1988-05-20 GB GB8811929A patent/GB2205837B/en not_active Expired - Fee Related
- 1988-05-20 SE SE8801903A patent/SE503210C2/sv not_active IP Right Cessation
- 1988-05-20 DE DE3817375A patent/DE3817375C2/de not_active Expired - Fee Related
- 1988-05-20 FI FI882384A patent/FI89493C/fi not_active IP Right Cessation
- 1988-05-20 IT IT20682/88A patent/IT1217685B/it active
- 1988-05-21 CN CN198888103091A patent/CN88103091A/zh active Pending
- 1988-05-21 PL PL1988272597A patent/PL154877B1/pl unknown
- 1988-05-21 JP JP63124809A patent/JP2680347B2/ja not_active Expired - Lifetime
- 1988-05-21 KR KR1019880006020A patent/KR880013958A/ko not_active Ceased
- 1988-05-24 FR FR8806885A patent/FR2615508B1/fr not_active Expired - Fee Related
- 1988-05-24 CH CH1967/88A patent/CH676984A5/fr not_active IP Right Cessation
- 1988-05-24 NL NL8801330A patent/NL8801330A/nl not_active Application Discontinuation
- 1988-05-24 BE BE8800566A patent/BE1004193A3/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPS6456689A (en)	1989-03-03
IL86464A (en)	1993-06-10
KR880013958A (ko)	1988-12-22
IE881543L (en)	1988-11-22
PL154877B1 (en)	1991-09-30
FI882384A7 (fi)	1988-11-23
DK277488D0 (da)	1988-05-20
CN88103091A (zh)	1988-12-21
PT87539A (pt)	1989-05-31
CH676984A5 (da)	1991-03-28
NL8801330A (nl)	1988-12-16
AU610591B2 (en)	1991-05-23
PH25350A (en)	1991-05-13
PT87539B (pt)	1992-09-30
NZ224733A (en)	1990-12-21
ES2009918A6 (es)	1989-10-16
GB2205837A (en)	1988-12-21
IE930324L (en)	1988-11-22
GB8811929D0 (en)	1988-06-22
IL86464A0 (en)	1988-11-15
NO882218L (no)	1988-11-23
IT8820682A0 (it)	1988-05-20
IE63760B1 (en)	1995-06-14
DE3817375A1 (de)	1988-12-08
SE8801903D0 (sv)	1988-05-20
FI882384A0 (fi)	1988-05-20
FI89493B (fi)	1993-06-30
DE3817375C2 (de)	1997-04-30
FI89493C (fi)	1993-10-11
IT1217685B (it)	1990-03-30
FR2615508A1 (fr)	1988-11-25
SE503210C2 (sv)	1996-04-22
HU205125B (en)	1992-03-30
NO882218D0 (no)	1988-05-20
FR2615508B1 (fr)	1994-11-25
GR880100331A (en)	1989-02-23
AU1650888A (en)	1988-11-24
SE8801903L (sv)	1988-11-23
GR1000959B (el)	1993-03-16
HUT49358A (en)	1989-09-28
GB2205837B (en)	1991-11-20
BE1004193A3 (fr)	1992-10-13
JP2680347B2 (ja)	1997-11-19
PL272597A1 (en)	1989-03-06

Legal Events

Date	Code	Title	Description
2000-01-17	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK277488D0 (da)	1988-05-20	Phosporholdige hmg-coa-reduktaseinhibitorer, deres anvendelse og fremstilling samt mellemprodukter ved fremstillingen
NO177212C (no)	1995-08-09	Fremgangsmåte ved fremstilling av deig og bröd, samt enzympreparat for anvendelse ved fremgangsmåten
DK328585D0 (da)	1985-07-18	Modificerede succinimider, fremgangsmaade til deres fremstilling samt deres anvendelse
DE3681991D1 (de)	1991-11-21	Hmg-coa-reduktase-hemmungskoerper.
DE68904083D1 (de)	1993-02-11	Hmg-coa-reduktaseinhibitoren.
DK198387D0 (da)	1987-04-15	1-hydroxy-2-pyridoner, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter og disses fremstilling
DE68901091D1 (de)	1992-05-07	Hmg-coa-reduktaseinhibitoren.
DK148590A (da)	1990-06-18	Homogene, isaer flerfarvede strukturerede kunststofbaner eller -plader samt fremgangsmaade til deres fremstilling
DK698088A (da)	1989-06-18	Piperidinylforbindelser, deres anvendelse samt mellemprodukter til brug ved fremstillingen af disse
DK277388A (da)	1988-11-23	Phosphorholdige hmg-coa-reduktase-inhibitorer, mellemprodukter og fremgangsmaade
NO884270D0 (no)	1988-09-27	Alkadienderivater, deres fremstilling og mellomprodukter til bruk ved fremstillingen.
ZA886468B (en)	1989-04-26	Novel hmg-coa reductase inhibitors
FI893004A7 (fi)	1989-12-30	5-oksygenoituja HMG-CoA-reduktaasi-inhibiittoreita
DK361288D0 (da)	1988-06-30	Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling
DK332287D0 (da)	1987-06-29	Antibiotika ll-e19020-alfa og ll-e19020-beta, deres fremstilling og anvendelse samt mikroorganisme til fremstillingen
NO903801D0 (no)	1990-08-30	Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav.
DK436388A (da)	1989-04-07	Substituerede pyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK610388A (da)	1989-05-04	(6-(hetero) aryloxy-naphthalin-2-yl-oxy)-alkancarboxylsyrederivater, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter og disses fremstilling
DK192989A (da)	1989-10-22	3,4-dihydroxypyrrolidin-2-on-derivater, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter
NO880628L (no)	1988-08-15	Annelerte azepinon- og azocinon-derivater, fremgangsmaate til deres fremstilling, midler som inneholder dem og deresanvendelse, samt mellomprodukter ved deres fremstilling.
DK490985A (da)	1986-04-28	Benzoylurinstoffer, deres fremstilling og anvendelse, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
NO900973D0 (no)	1990-03-01	Kasseformet foldeemballasje og emne til bruk ved fremstilling av samme.
EP0306263A3 (en)	1989-08-23	Novel hmg-coa reductase inhibitors
NO901934D0 (no)	1990-04-30	Fraktureringsmateriale, samt anvendelse av det ved produksjon av hydrokarboner.
DK548487A (da)	1988-04-22	Substituerede aminoketaler, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige dioxalaner og disses fremstilling